Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00375973 · ClinicalTrials.gov registry record · Phase 2
Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome
A Phase 2 study, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT00375973 is a Phase 2 study that has completed, run by University of Cincinnati. The registered enrollment target is 60 participants.
The verdict
NCT00375973, a Phase 2 study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and efficacy of duloxetine compared with placebo for reducing fatigue in patients diagnosed with Chronic Fatigue Syndrome (CFS).
Interventions
- DRUG Placebo
- DRUG Duloxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-09 |
| Est. Completion | 2014-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00375973
The ClinicalTrials.gov registry entry for NCT00375973 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00375973 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00375973 about?
NCT00375973 is a clinical study titled "Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome". The purpose of this study is to determine the safety and efficacy of duloxetine compared with placebo for reducing fatigue in patients diagnosed with Chronic Fatigue Syndrome (CFS).
What is the current status of trial NCT00375973?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2006-09. Estimated completion is 2014-03.
What interventions are being tested in trial NCT00375973?
The interventions under investigation include: Placebo (DRUG), Duloxetine (DRUG).
Who is sponsoring clinical trial NCT00375973?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.